Related Experiment Video
Updated: Apr 22, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.7K
Neoadjuvant 90 Yttrium peptide receptor radionuclide therapy for advanced rectal neuroendocrine tumour: a case report
Jennifer Ryan1,2, Timothy Akhurst3, A Craig Lynch1
1Department of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
ANZ Journal of Surgery
|October 14, 2014
Abstract
No abstract available in PubMed .

